Light-based visual cues to indicate drug delivery

Abstract

The wireless receiver may be configured to receive a plurality of wireless communications from the computing device. The first light source may be activated based on a first wireless communication of the plurality of wireless communications. The activation of the first light source may be a first visual cue for performing a first step of the plurality of steps of the instructions for use of the medication delivery device, and the first light source may be activated in response to the first step being displayed by the computing device. The second light source may be activated based on a second wireless communication of the plurality of wireless communications. The activation of the second light source may be a second visual cue for performing a second step of the plurality of steps, and the second light source may be activated in response to the second step being displayed by the computing device.

Description

[Technical field]

[0001] The present disclosure relates generally to providing light-based visual cues to assist a patient in the proper use of a drug delivery device, such as, for example, a drug injection device. A light source, such as an organic light-emitting diode (OLED), may be activated to cue a user to perform various drug delivery instructions, such as in a corresponding sequence. [Background technology]

[0002] The drug delivery device may be used to store and / or deliver a drug. In some examples, the drug delivery device may be a drug injection device such as a pre-filled syringe, an auto-injector, or a wearable injection pump. In some other examples, the drug delivery device may be a drug containment container such as a bottle, a blister pack, or other drug packaging.

[0003] Patients often do not properly perform an injection by failing to remove the cap of the drug delivery device, not depressing the drug delivery device sufficiently to inject the full dose, failing to lift the drug delivery device after injection, etc. Additionally, patients may neglect to perform other drug delivery steps, such as shaking the drug before use.

[0004] Drug delivery instructions may be printed on a product label or instruction sheet. However, users often neglect to read the printed instructions or may not fully understand the instructions. Furthermore, the printed instructions may not tell the user exactly which step of the process they are currently performing, which may cause steps and instructions to be missed or otherwise performed improperly. Summary of the Invention [Means for solving the problem]

[0005] An exemplary light-based drug delivery cue system is described. The system may include a wireless receiver configured to receive a plurality of wireless communications from a computing device via a wireless communication protocol. The system may further include a first light source that is activated based on a first wireless communication of the plurality of wireless communications. The activation of the first light source may be a first visual cue for performing a first step of a plurality of steps of instructions for use of the drug delivery device. The first light source may be activated in response to the first step being displayed by the computing device. The system may further include a second light source that is activated based on a second wireless communication of the plurality of wireless communications. The activation of the second light source may be a second visual cue for performing a second step of a plurality of steps associated with the instructions for use. The second light source may be activated in response to the second step being displayed by the computing device. The second wireless communication may be transmitted based on a user input to the computing device.

[0006] An exemplary light-based drug delivery cue method is also described. The method may include receiving a first wireless communication by the wireless receiver from the computing device via the wireless communication protocol. The method may further include activating a first light source based on the first wireless communication. The activation of the first light source may be a first visual cue for performing a first step of a plurality of steps of the instructions for use of the drug delivery device. The first light source may be activated in response to the first step being displayed by the computing device. The method may further include receiving a second wireless communication by the wireless receiver from the computing device via the wireless communication protocol. The second wireless communication may be transmitted based on a user input to the computing device. The method may further include activating a second light source based on the second wireless communication. The activation of the second light source may be a second visual cue for performing a second step of a plurality of steps associated with the instructions for use. The second light source may be activated in response to the second step being displayed by the computing device. [Brief description of the drawings]

[0007] For a more complete understanding of the principles disclosed herein and their advantages, reference is now made to the following descriptions taken in conjunction with the accompanying drawings, in which: [Figure 1A] FIG. 2 is a front view of a first exemplary medication delivery device in a pre-use position. [Figure 1B] FIG. 2 is a front view of a first exemplary medication delivery device with the cap removed to expose the needle guard. [Figure 1C] FIG. 1C is a front view of the first exemplary medication delivery device with the needle guard moved from the position of FIG. 1B. [Figure 1D] FIG. 2 is a front view of a first exemplary medication delivery device with the upper housing moving towards a dispensing position. [Figure 1E]FIG. 2 is a front view of a first exemplary medication delivery device with the upper housing in a dispensing position. [Figure 1F] FIG. 2 is a front view of a first exemplary medication delivery device with the needle guard in a final position. [Diagram 2] FIG. 2 is a diagram of a second exemplary drug delivery device, which is an exemplary pre-filled syringe. [Diagram 3] FIG. 13 is a diagram of a third exemplary drug delivery device, which is an exemplary auto-injector. [Figure 4] FIG. 13 is a diagram of a fourth exemplary drug delivery device, which is an exemplary wearable drug delivery device. [Diagram 5] FIG. 1 illustrates a first exemplary computing device page and a light source integrated with a first exemplary medication delivery device. [Figure 6] FIG. 11 is a diagram of a second exemplary computing device page and an exemplary corresponding light source activation. [Figure 7] FIG. 13 is a diagram of a third example computing device page and an example corresponding light source activation. [Figure 8] FIG. 13 is a diagram of a fourth exemplary computing device page and an exemplary corresponding light source activation. [Figure 9] FIG. 5 is a diagram of a fifth exemplary computing device page and an exemplary corresponding light source activation. [Figure 10] FIG. 6 is a diagram of a sixth exemplary computing device page and an exemplary corresponding light source activation. [Figure 11] FIG. 1 is a diagram of an exemplary light-based drug delivery cueing system. [Figure 12] FIG. 1 is a flow diagram of an exemplary light-based drug delivery cueing process. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0008] While the concept of the present disclosure is susceptible to various modifications and alternative forms, certain exemplary embodiments thereof are shown by way of example in the drawings and will be described in detail herein. It should be understood, however, that there is no intention to limit the concept of the present disclosure to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives encompassed within the spirit and scope of the invention as defined by the appended claims. Furthermore, a structure described as "at least one," as used herein, can refer to a single one of the described structures, as well as either or both of a plurality of the described structures. Additionally, references to the singular forms "a," "an," or "the" apply equal force and effect to the plural, unless otherwise indicated. Similarly, references to the plural herein apply equal force and effect to the singular forms "a," "an," or "the."

[0009] References herein to "one embodiment," "an embodiment," "an exemplary embodiment," and the like indicate that the embodiment being described may include a particular feature, structure, or characteristic, but not all embodiments necessarily include that particular feature, structure, or characteristic. Moreover, such phrases do not necessarily refer to the same embodiment. Furthermore, when a particular feature, structure, or characteristic is described in connection with an embodiment, the effect of such feature, structure, or characteristic on other embodiments, whether or not explicitly described, is intended to be within the knowledge of one of ordinary skill in the art.

[0010] Exemplary Drug Delivery Devices Several exemplary drug delivery devices are described herein in association with which the described light-based visual cue techniques may be implemented. The term drug delivery device, as used herein, refers to a device used to store and / or deliver a drug. Drug delivery devices may include, for example, drug injection devices and drug storage containers. In some examples, the light-based visual cue techniques described herein may be implemented in association with drug injection devices, such as auto-injectors, pre-filled syringes, wearable drug delivery devices (e.g., patch pumps, on body delivery systems (OBDS), etc.). However, it should be noted that the techniques described herein are not limited to use with any particular type of drug delivery device, and a wide variety of types of drug delivery devices may be used.

[0011] 1A-1F, a first exemplary medication delivery device is described in connection with which the described light-based visual cue technology may be implemented. As described, the device 300 may be used to inject medication, such as by depressing the upper housing 308 and moving the upper housing from a pre-use position to an administration position. In operation, and with reference to FIGS. 1A-1F, the device 300 may be configured to deliver medication. Before use, the upper housing 308 may be locked in a pre-use position, and the cap 320 may be coupled to the lower housing 304 to shield the needle guard 316 and the needle 332. When the device 300 is ready to be used, the cap 320 may be removed from the lower housing 304, as shown in FIG. 1B.

[0012] As shown in FIG. 1C, the device 300 can be positioned against the skin surface and a manual force can be applied to the upper housing 308 along an insertion direction (which is direction X2 in FIG. 1A ) such that the needle guard 316 is pressed against the skin surface, the needle guard 316 moves, and the needle 332 is inserted into tissue. As the needle guard 316 moves, the upper housing 308 can be unlocked from the pre-use position. As shown in FIG. 1D and FIG. 1E , the upper housing 308 can then be moved over the middle housing 312 along the insertion direction. The upper housing 308 of the device 300 is supported relative to the lower housing 304 and is configured to receive a manual force and, in response to the force, move from a pre-use position to a dispensing position along the insertion direction relative to the lower housing 304. The device 300 may include an internal syringe supported by the lower housing 304, and a plunger rod carried by the upper housing 308 and movable with the upper housing 308 to advance relative to the syringe as the upper housing 308 is moved along an insertion direction. The syringe may be configured to hold a medicament and may carry a needle 332 configured to be inserted into tissue. Advancement of the plunger rod relative to the syringe may cause the syringe to deliver the medicament from the needle 332 into the tissue. Once the upper housing 308 reaches the dispensing position, the upper housing 308 may be locked in the dispensing position, for example, via an internal locking latch and latch member, to prevent reuse of the device 300. Once the upper housing 308 is locked in the dispensing position, such as by snapping the locking latch into the latch member, an audible click may be generated to inform the user that the upper housing 308 has reached the dispensing position and is locked in the dispensing position. The upper housing 308 may be permanently locked in the dispensing position such that the device 300 cannot be reused. However, it should be understood that the upper housing 308 may be temporarily locked so that the device 300 can be sterilized and reused.

[0013] 1F, as device 300 is removed from the skin surface along a direction X1 opposite to the insertion direction, needle guard 316 moves along the insertion direction to a final position. When in the final position, needle guard 316 may be permanently locked in the final position such that device 300 cannot be reused. However, it should be understood that needle guard 316 may be temporarily locked so that device 300 can be sterilized and reused.

[0014] 1A-1F is one example of a drug delivery device that may implement the light-based visual cue techniques described herein. However, the light-based visual cue techniques described herein may also be implemented in association with other drug delivery devices, such as auto-injectors, pre-filled syringes, wearable drug delivery devices (e.g., patch pumps, OBDS), etc.

[0015] Referring now to FIG. 2, device 400 is an example of a pre-filled syringe in which the light-based visual cue techniques described herein may be implemented. As shown in FIG. 2, device 400 has a cap 420 that may be removed by the user when the user is ready to use device 400 to inject a medication. After removing cap 420, device 400 may be held and needle 414 may be inserted. The user may then place their thumb on plunger 412 and fully depress plunger 412 until plunger 412 stops. The user may then release pressure from plunger 412. Needle 414 may then retract into body 411. Thus, in device 400, the user depresses plunger 412, as opposed to, for example, upper housing 308 of device 300 of FIG. 3.

[0016] Referring now to FIG. 3, device 500 is an example of an auto-injector in which the light-based visual cue techniques described herein may be implemented. As shown in FIG. 2, device 500 has a cap 520 that may be removed by the user when the user is ready to use device 500 to inject medication. After removing cap 520, the user may hold device 500 and position device 500 against the skin with safety sleeve 516 flat against the skin. The user may then press firmly against the skin, which causes safety sleeve 516 to slide into cover 517. The user may then press button 518, which may cause medication to be injected into the user through a hidden needle, which may be located adjacent safety sleeve 516 and cover 517. Device 500 may generate an audible sound, such as a first click, when button 518 is pressed and injection of medication begins. The user may continue to press button 518 until medication is fully administered. 3, device 500 may also generate an audible sound, such as a click, once the medication is fully administered, and this second click may indicate to the user that the medication has been fully administered. Upon hearing the second click, the user may lift device 500 from the skin. Thus, one way in which device 500 differs from device 300 is that device 500 allows an injection to be triggered by pressing button 518.

[0017] Referring now to FIG. 4, device 600 is an example of a wearable drug delivery device in which the light-based visual cue techniques described herein may be implemented. Device 600 may be an on-body delivery system (OBDS) or may be included in an on-body delivery system. FIG. 4 shows a front side 601 of device 600. In some examples, 600 may be attachable to a user's skin. For example, a rear side of device 600 (not shown in FIG. 4), which may be opposite front side 601 in some cases, may have an attached adhesive pad that may enable attachment of device 600 to a user's skin. Also, in some examples, device 600 may have an associated strap to assist in attaching device 600 to a user's skin. As shown in FIG. 4, drug tube 603 is visible through window 602. In operation, device 600 may deliver drug from drug tube 603 to a user via injection. In the example of FIG. 4, a user may press button 604 to initiate the injection process. The device 600 may include a needle that may protrude from the rear of the device 600, through which an injection of a medication may be delivered.

[0018] Thus, as noted above, the light-based visual cue techniques described herein may be implemented in association with medication delivery devices, such as auto-injectors, pre-filled syringes, wearable medication delivery devices (e.g., patch pumps, on-body delivery systems (OBDS), etc.). However, it should again be noted that the techniques described herein are not limited to use with any particular type of medication delivery device, and a wide variety of types of medication delivery devices may be used. As another example, the light-based visual cue techniques described herein may also be used in combination with other medication delivery devices, such as medication storage containers (e.g., storage bottles, blister packs, other storage packages, etc.).

[0019] Light-based visual cues to indicate drug delivery As described herein, the light-based drug delivery cue system may include an illumination circuit integrated with the drug delivery device. The illumination circuit may include a light source. In some examples, any or all of the light sources described herein may be thin, flat, and / or flexible components, such as organic light-emitting diodes (OLEDs) and / or OLED displays, so as not to cause substantial changes to the size and / or shape of the drug delivery device. Also, in some examples, other light sources may be used, such as light-emitting diodes (LEDs), LED displays, other thin-film lights, incandescent lights, and / or other light sources. Also, as described herein, the illumination circuit may include a wireless receiver that receives wireless communications from a computing device (e.g., a smartphone, a tablet, a laptop, etc.) via a wireless communication protocol, such as Bluetooth, Near-Field Communication (NFC), etc. The light source may be activated based on the communication received from the computing device. The light source may be activated to assist the user in the injection process, such as by providing visual cues for performing various steps of the injection process (e.g., remove the cap, place the device on the skin, press down on the handle, press until you hear a click, lift up, etc.) Activating the light source means that the light source is caused to assume one or more activation states, to begin emitting light (e.g., by being powered on), to begin flashing, to change color (e.g., to green or another designated color associated with an activation state), etc.

[0020] Patients may often perform an injection improperly by failing to remove the cap of the drug delivery device, not depressing the drug delivery device sufficiently to inject the full dose, failing to lift the drug delivery device after injection, etc. By using light-based cues of the steps of the injection process, the likelihood that a user will perform the injection process improperly is reduced.

[0021] 5, an example is shown in which light source 5021, light source 5022, and light source 5023 (collectively referred to as light sources 5021-5023) are integrated with device 300. In some examples, light sources 5021-5023 may be included in one or more adhesive labels attached to device 300. In other examples, light sources 5021-5023 may be components of device 300. In this example, light source 5021 is located on cap 320. Light sources 5022 and 5023 are located on upper housing 308. Light source 5021 has the shape of a horizontal arrow, which is a cue for the user to remove cap 320. Light source 5022 is a downward arrow, which is a cue for the user to press down on device 300. Light source 5023 is an upward arrow, which is a cue for the user to lift device 300. FIG. 5 shows light sources 5021-5023 before the start of injection of the medication. Therefore, in the example of FIG. 5, none of the light sources 5021-5023 are activated.

[0022] FIG. 5 also illustrates a computing device 5000, such as a smartphone, tablet, or laptop. The computing device displays a page 5010. The page 5010 includes a back button 5011 and a forward button 5012. A user may select (e.g., click) the back button 5011 to indicate that they want to return to a previous step in the injection process. In contrast, a user may select (e.g., click) the forward button 5012 to indicate that they are ready to proceed to the next step in the injection process. The page 5010 includes instructions 5001, which include text indicating a current step in the injection process that the user should perform. In some examples, the instructions 5001 may include text and / or images that describe the corresponding step in the injection process. The instructions 5001 indicate that the user should click the forward button 5012 when the user is ready to begin the injection process.

[0023] As described in more detail below with reference to FIG. 11, the computing device 5000 may transmit wireless communications via the wireless transmitter 5621 to the wireless receiver 5603 of FIG. 11, which may be integrated with a drug delivery device 5610, such as the device 300. Thus, it should be understood that the communications transmitted from the computing device 5000 to the device 300 described with reference to FIGS. 5-10 may be implemented via the wireless transmitter 5621 and the wireless receiver 5603 of FIG. 11. When the user selects the forward button 5012 from the page 5010, this indicates that the user is ready to begin the injection process. In response to this user input (e.g., selection of the forward button 5012 from the page 5010), the computing device 5000 may transmit a communication to the device 300 indicating that the light source 5021 should be activated.

[0024] Referring now to FIG. 6, an example of the device 300 is shown after the user selects the proceed button 5012 from the page 5010 of FIG. 5. In this example, the first step of the injection process is for the user to remove the cap 320 of the device 300. Thus, in FIG. 6, the light source 5021 is activated to signal the user to remove the cap 320. As explained above, the light source 5021 has the shape of a horizontal arrow, which is a signal for the user to remove the cap 320. In FIG. 6, the light source 5021 is shown with a thick / bold outline to indicate that the light source 5021 is currently activated. In contrast, in FIG. 6, the light sources 5022 and 5023 have a thin outline, which indicates that the light sources 5022 and 5023 are not activated. The light source 5021 (as well as other light sources described herein) may be activated by changing to one or more activation states to begin emitting light (e.g., by being powered on), to begin flashing, to change color (e.g., to green or another designated color associated with an activation state), etc.

[0025] 6, selecting forward button 5012 from page 5010 of FIG. 5 causes computing device 5000 to load the next page (e.g., page 5110). Page 5110 includes instructions 5101, which include text indicating a current step in the injection process that the user should perform. In some examples, instructions 5101 may include text and / or images that describe the corresponding step in the injection process. Instructions 5001 indicate that the user should remove cap 320.

[0026] Thus, activation of light source 5021 may signal the user to remove cap 320. After removing cap 320, the user may select forward button 5012 from page 5110. When the user selects forward button 5012 from page 5110, this indicates that the user has successfully removed cap 320 from device 300. In response to this user input (e.g., selection of forward button 5012 from page 5110), computing device 5000 may send a communication to device 300 indicating that light source 5021 should be deactivated. Deactivating a light source means that the light source is released from the state it had when it was activated, such as by ceasing to emit light (e.g., by being powered off), ceasing to blink, changing color (e.g., changing back to the color it had before it was activated), etc. Additionally, in response to this user input (e.g., selection of forward button 5012 from page 5110), computing device 5000 may send a communication to device 300 indicating that light source 5024 (shown in FIG. 7) should be activated. The communications to deactivate light source 5021 and activate light source 5024 may be sent via a single combined communication or multiple communications.

[0027] Referring now to FIG. 7, an example of the device 300 is shown after a user selects the proceed button 5012 from page 5110 of FIG. 6. In this example, the next step in the injection process is for the user to place the device 300 on their skin. Thus, in FIG. 7, the light source 5024 is activated to cue the user to place the device 300 on the user's skin. Note that in FIGS. 5 and 6, the light source 5024 is obscured (and therefore not shown) by the cap 320. In some examples, the light source 5024 may alternatively be located closer to the distal end D of the device 300. In FIG. 7, the light source 5024 is shown with a thick / bold outline to indicate that the light source 5024 is currently activated. In contrast, in FIG. 7, the light sources 5022 and 5023 have a thin outline, indicating that the light sources 5022 and 5023 are not activated.

[0028] 7, selecting forward button 5012 from page 5110 of FIG. 6 causes computing device 5000 to load the next page (e.g., page 5210). Page 5210 includes instructions 5201, which include text indicating a current step in the injection process that the user should perform. In some examples, instructions 5201 may include text and / or images that describe the corresponding step in the injection process. Instructions 5201 indicate that the user should place device 300 on their skin.

[0029] Thus, activation of light source 5024 may signal the user to place device 300 on the user's skin. After the user places device 300 on their skin, the user may select forward button 5012 from page 5210. When the user selects forward button 5012 from page 5210, this indicates that the user has successfully placed device 300 on their skin. In response to this user input (e.g., selection of forward button 5012 from page 5210), computing device 5000 may send a communication to device 300 indicating that light source 5024 should be deactivated. Additionally, in response to this user input (e.g., selection of forward button 5012 from page 5210), computing device 5000 may send a communication to device 300 indicating that light source 5022 should be activated. The communications to deactivate light source 5024 and activate light source 5022 may be sent via a single combined communication or multiple communications.

[0030] Referring now to FIG. 8, an example of the device 300 is shown after a user selects the proceed button 5012 from page 5210 of FIG. 7. In this example, the next step in the injection process is for the user to press down on the handle (e.g., the handle shape formed by the upper housing 308). Thus, in FIG. 8, the light source 5022 is activated to signal the user to press down on the handle. As explained above, the light source 5022 has a downward arrow shape that is a signal for the user to press down on the handle. In FIG. 8, the light source 5022 is shown with a thick / bold outline to indicate that the light source 5022 is currently activated. In contrast, in FIG. 8, the light sources 5023 and 5024 have a thin outline, indicating that the light sources 5023 and 5024 are not activated.

[0031] 8, selecting forward button 5012 from page 5210 of FIG. 7 causes computing device 5000 to load the next page (e.g., page 5310). Page 5310 includes instructions 5301, which include text indicating a current step in the injection process that the user should perform. In some examples, instructions 5301 may include text and / or images that describe the corresponding step in the injection process. Instructions 5301 indicate that the user should press down on the handle.

[0032] Thus, activation of light source 5022 may signal the user to press down the handle. After pressing down the handle, the user may select forward button 5012 from page 5310. When the user selects forward button 5012 from page 5310, this indicates that the user has pressed down the handle.

[0033] 9, an example of the device 300 is shown after a user selects the proceed button 5012 from page 5310 of FIG. 8. In this example, the next step in the injection process is for the user to continue to press the handle until a click is heard. For example, as described above, the device 300 may emit a click when the injection of the medication is complete. Specifically, as described above in connection with FIGS. 1A-1F, when the upper housing 308 is locked into the dispensing position, such as by snapping a locking latch onto a latching member, an audible click may be generated to inform the user that the upper housing 308 has reached and is locked into the dispensing position. Thus, in FIG. 9, the light source 5022 remains activated to signal the user to continue to press the handle until a click is heard. As described above, the light source 5022 has the shape of a downward arrow, which is a signal to the user to continue to press the handle until a click is heard. In FIG. 9, the light source 5022 is shown with a thick / bold outline to indicate that the light source 5022 is currently activated. In contrast, in FIG. 9, light sources 5023 and 5024 have a thin outline, indicating that light sources 5023 and 5024 are not activated.

[0034] 9, selecting forward button 5012 from page 5310 of FIG. 8 causes computing device 5000 to load the next page (e.g., page 5410). Page 5410 includes instructions 5401, which include text indicating the current step in the injection process that the user should perform. In some examples, instructions 5401 may include text and / or images that describe the corresponding step in the injection process. Instructions 5401 indicate that the user should press and hold until a clicking sound is heard.

[0035] After the user hears the click, the user may select the forward button 5012 from page 5410. When the user selects the forward button 5012 from page 5410, which indicates that the user hears a click and the dose of medication has been fully injected. In response to this user input (e.g., selection of the forward button 5012 from page 5410), the computing device 5000 may send a communication to the device 300 indicating that the light source 5022 should be deactivated. Additionally, in response to this user input (e.g., selection of the forward button 5012 from page 5410), the computing device 5000 may send a communication to the device 300 indicating that the light source 5023 should be activated. The communications to deactivate the light source 5022 and activate the light source 5023 may be sent via a single combined communication or multiple communications.

[0036] Referring now to FIG. 10, an example of the device 300 is shown after a user selects the proceed button 5012 from page 5410 of FIG. 9. In this example, the next step in the injection process is for the user to lift the device 300. Thus, in FIG. 9, the light source 5023 is activated to signal the user to lift the device 300. As explained above, the light source 5023 has the shape of an upward arrow, which is a signal for the user to lift the device 300. In FIG. 10, the light source 5023 is shown with a thick / bold outline to indicate that the light source 5023 is currently activated. In contrast, in FIG. 10, the light sources 5022 and 5024 have a thin outline, which indicates that the light sources 5022 and 5024 are not activated.

[0037] 10, selecting forward button 5012 from page 5410 of FIG. 9 causes computing device 5000 to load the next page (e.g., page 5510). Page 5510 includes instructions 5501, which include text indicating a current step in the injection process that the user should perform. In some examples, instructions 5501 may include text and / or images that describe the corresponding step in the injection process. Instructions 5501 indicate that the user should lift device 300. Instructions 5501 also indicate that the injection is complete.

[0038] Thus, activation of light source 5023 may signal the user to lift device 300. Activation of light source 5023 is also a visual indicator on device 300 that the injection is complete. After lifting device 300, the user may select forward button 5012 from page 5510. When the user selects forward button 5012 from page 5510, this indicates that the user has lifted device 300. In response to this user input (e.g., selection of forward button 5012 from page 5510), computing device 5000 may send a communication to device 300 indicating that light source 5023 should be deactivated.

[0039] 11, an example of a light-based drug delivery cueing system 5690 will now be described in detail. As shown, the light-based drug delivery cueing system 5690 includes an illumination circuit 5600, a drug delivery device 5610, and a computing device 5620. In one particular example, the drug delivery device 5610 may be the device 300 of FIGS. 1A-1F.

[0040] The lighting circuitry 5600 may be integrated with the drug delivery device 5610. The term "integrated" as used herein means that the lighting circuitry 5600 is included within the drug delivery device 5610 or is otherwise physically connected or attached (e.g., via an adhesive, etc.) directly or indirectly (e.g., via one or more connection or attachment components) to the drug delivery device 5610 before and / or when the drug delivery device is used by the patient (and / or by another user on behalf of the patient). Thus, the battery 5604, the wireless receiver 5603, the processing component 5630, the switch 5601, the light source 5611, the switch 5602, and the light source 5612 may be integrated with the drug delivery device 5610. In some examples, the lighting circuitry 5600 may be included in one or more thin, flexible adhesive labels that are attachable to and / or attached to the drug delivery device 5610. Thus, in some examples, any or all of the battery 5604, wireless receiver 5603, processing component 5630, switch 5601, light source 5611, switch 5602, and light source 5612 may be included in one or more thin, flexible adhesive labels that are attachable and / or attached to the drug delivery device 5610. Additionally, in some examples, the lighting circuitry 5600 may be included within the drug delivery device 5610. For example, the lighting circuitry 5600 may be embedded in one or more other components of the drug delivery device 5610, for example, by being molded into the plastic and / or other material that may comprise those components. Thus, in some examples, any or all of the battery 5604, wireless receiver 5603, processing component 5630, switch 5601, light source 5611, switch 5602, and light source 5612 may be included within the drug delivery device 5610.

[0041] In some examples, the computing device 5620 may be a smartphone, tablet, or laptop. In this example, the computing device 5620 includes a display 5624, such as a touch screen, monitor, or other display screen. The display 5624 may be used to display pages 5010, 5110, 5210, 5310, 5410, and 5510 of FIGS. 5-10. These pages may be displayed via a graphical user interface (GUI). The computing device 5620 also includes an input component 5623, via which user input may be received. In some examples, the display 5624 may also be the input component 5623, such as when the display 5624 is a touch screen. In other examples, the input component 5623 may be a different component, such as a mouse or a keyboard. The computing device 5620 may also include an application 5622 to generate pages 5010, 5110, 5210, 5310, 5410, and 5510 of FIGS. 5-10. The application 5622 may also receive user input, such as selection of forward button 5012. In response to the user input, the application 5622 may cause a wireless communication to be transmitted to the wireless receiver 5603, the wireless communication including instructions to activate the light sources 5611 and 5612, as described in more detail below. The application 5622 may be a web browser or another application, such as an application that specifically enables interaction with and control of the lighting circuit 5600. The wireless transmitter 5621 transmits the wireless communication via a wireless communication protocol, such as a short-range wireless communication protocol (e.g., Bluetooth, Near Field Communication (NFC), etc.).

[0042] The computing device 5620 further includes a processing component 5625 and a memory component 5626. A computing device, as the term is used herein, refers to a device including at least a processing component 5625 and a memory component 5626 that are programmable to perform computing operations. The processing component 5625 may be a general-purpose computer processor. The memory component 5626 may be volatile (such as some types of RAM), non-volatile (such as ROM, flash memory, etc.), or a combination thereof. The memory component 5626 may include additional storage devices (e.g., removable and / or non-removable storage devices), including, but not limited to, tape, flash memory, smart cards, CD-ROMs, digital versatile disks (DVDs) or other optical storage devices, magnetic cassettes, magnetic tapes, magnetic disk storage devices or other magnetic storage devices, universal serial bus (USB) compatible memory, or any other medium that can be used to store information and that can be accessed by the computing device 5620. The memory component 5626 can store therein instructions that, when executed by the processing component 5625, cause the computing device 5620 to perform operations, such as those performed by the computing device 5620, described herein.

[0043] The lighting circuit 5600 includes a battery 5604, a wireless receiver 5603, a processing component 5630, switches 5601 and 5602, and light sources 5611 and 5612. The battery 5604 may power the wireless receiver 5603, the processing component 5630, and, when activated, the light sources 5611 and 5612. The processing component 5630 may be a component that is programmed or otherwise instructed to perform operations as described herein and may be included in one or more integrated circuit (IC) chips and / or other IC components. The wireless receiver 5603 is configured to receive a plurality of wireless communications from the computing device 5620 (e.g., from the wireless transmitter 5621) via a wireless communication protocol. In some examples, the light source 5611 may be any of the light sources 5021, 5022, 5023, and 5024 described above. Additionally, in some examples, the light source 5612 may be any of the light sources 5021, 5022, 5023, and 5024 described above. Further, in some examples, the lighting circuit 5600 may optionally include any number of additional light sources and any number of additional switches (indicated by the ellipsis shown in FIG. 11 ).

[0044] Specifically, a user may provide a first user input to application 5622 of computing device 5620. In one particular example, the first user input may indicate that the user is ready to begin the injection process. For example, this may include selection of forward button 5012 of page 5010 of FIG. 5. Upon receiving the first user input, application 5622 may cause wireless transmitter 5621 to transmit a first wireless communication of the multiple wireless communications to wireless receiver 5603. This first wireless communication may include instructions to activate light source 5611. Receipt of the first user input by computing device 5620 (e.g., by application 5622) may also cause computing device 5620 (e.g., application 5622) to load a new display page, such as by switching display 5624 from page 5010 of FIG. 5 to page 5110 of FIG. 6.

[0045] The first wireless communication may be received by the wireless receiver 5603 and then by the processing component 5630. In response to receiving the first wireless communication, the processing component 5630 may activate the light source 5611. The light source 5611 may be activated by being changed to one or more activation states, such as to start emitting light (e.g., by being powered on), to start blinking, to change color (e.g., to green or another designated color associated with an activation state), etc. In the example of FIG. 6, the light source 5611 may be activated by being caused to emit light, such as by being powered on. Specifically, the light source 5611 may be initially unpowered, and the light source 5611 may remain unpowered until the first wireless communication is received by the processing component 5630. Once the first wireless communication is received by the processing component 5630, the light source 5611 may be powered on. The switch 5601 is an electrical switch that may control the flow of power from the battery 5604 to the light source 5611. The switch 5601 may initially be in an open state (not allowing power to be provided to the light source 5611) and then moved to a closed state (allowing power to be provided to the light source 5611) upon receipt of a first wireless communication by the processing component 5630. In some examples, upon receiving the first wireless communication, the processing component 5630 may provide a signal to close the switch 5601 and allow power to flow to the light source 5611. The processing component 5630 may additionally or alternatively provide one or more other signals to cause the light source 5611 to assume other operating states (e.g., flashing, changing color, etc.).

[0046] In one particular example, the light source 5611 can be the light source 5021 of Figure 6. Activation of the light source 5611 can be a visual cue to perform a first step of multiple steps of instructions for use of the drug delivery device 5610, such as delivering a drug to a user. In one particular example, the first step can be removing a cap of the drug delivery device 5610. As described above, activation of the light source 5021 of Figure 6 can be a visual cue to remove the cap 320 from the device 300.

[0047] Upon performing the first step (e.g., removing the cap), the user may provide a second user input to the application 5622 of the computing device 5620. The second user input may indicate to the computing device 5620 that the first step has been performed. For example, the second user input may include a selection of the forward button 5012 of the page 5110 of FIG. 6. Upon receiving the second user input, the application 5622 may cause the wireless transmitter 5621 to transmit a second wireless communication of the multiple wireless communications to the medication delivery device 5610. This second wireless communication may include instructions to activate the light source 5612 (and optionally deactivate the light source 5611). Receipt of a second user input by the computing device 5620 (e.g., by application 5622) may also cause the computing device 5620 (e.g., application 5622) to load a new display page, such as by switching the display 5624 from page 5110 of FIG. 6 to page 5210 of FIG. 7.

[0048] The second wireless communication may be received by the wireless receiver 5603 and, in turn, by the processing component 5630. In response to receiving the second wireless communication, the processing component 5630 may deactivate the light source 5611. The light source 5611 may be deactivated by being removed from the state it was in when activated. Thus, the light source 5611 may be deactivated by ceasing to emit light (e.g., by being powered off), ceasing to blink, changing color (e.g., changing back to the color it had before it was activated), etc. For example, in some cases, upon receiving the second wireless communication, the processing component 5630 may provide a signal to open the switch 5601 and prevent power from flowing to the light source 5611, thereby powering off the light source 5611 and causing it to stop emitting light.

[0049] Additionally, in response to receiving the second wireless communication, the processing component 5630 may also activate the light source 5612. The light source 5612 may be activated by being changed to one or more activation states, such as to start emitting light (e.g., by being powered on), to start blinking, to change color (e.g., to green or another designated color associated with an activation state), etc. In the example of FIG. 6, the light source 5612 may be activated by being caused to emit light, such as by being powered on. Specifically, the light source 5612 may be initially unpowered, and the light source 5612 may remain unpowered until the second wireless communication is received by the processing component 5630. Once the second wireless communication is received by the processing component 5630, the light source 5612 may be powered on. The switch 5602 is an electrical switch that may control the flow of power from the battery 5604 to the light source 5612. The switch 5602 may initially be in an open state (not allowing power to be provided to the light source 5612) and then moved to a closed state (allowing power to be provided to the light source 5612) upon receipt of a second wireless communication by the processing component 5630. In some examples, the processing component 5630 may provide a signal to close the switch 5602 and allow power to flow to the light source 5612 upon receiving the second wireless communication. The processing component 5630 may additionally or alternatively provide one or more other signals to cause the light source 5611 to assume other operating states (e.g., flashing, changing color, etc.).

[0050] In one particular example, the light source 5612 may be the light source 5024 of Fig. 7. Activation of the light source 5612 may be a visual cue to perform a second step of the steps of the instructions for using the drug delivery device 5610. In one particular example, the second step may be instructions to place the drug delivery device 5610 on the user's skin. As explained above, activation of the light source 5041 of Fig. 9 may be a visual cue to place the device 300 on the user's skin.

[0051] As discussed above, although not shown in Figure 11, the lighting circuit 5600 may include any number of additional light sources and respective switches. These additional light sources may also be activated based on additional communications received from the computing device 5620 by the wireless receiver 5603. Furthermore, these additional communications may be transmitted based on user input to the computing device 5620, such as a user input indicating that the user has performed a previous step in a specified sequence of steps.

[0052] In some examples, any or all of the lighting circuit components (e.g., wireless receiver 5603, light source 5611, switch 5601, light source 5612, switch 5602, processing component 5630, battery 5604) of the lighting circuit 5600 (and other lighting circuits described herein) may be implemented in whole or in part using one or more integrated circuit (IC) components, such as one or more IC chips. The integrated circuit components may be connected to one or more circuit boards, such as printed circuit boards and / or flexible circuit boards. The components may communicate and / or interact with each other via one or more electrical connections, for example via one or more circuit boards. Any or all of the lighting circuit components of the lighting circuit 5600 shown in FIG. 11 (and other lighting circuits described herein) may optionally include one or more processing components (e.g., integrated with or separate from the processing component 5630) and / or one or more memory components. The memory components may be volatile (such as some types of RAM), non-volatile (such as ROM, flash memory, etc.), or a combination of both.

[0053] 12, a process for light-based visual cues of medication delivery instructions will now be described in detail. The process of FIG. 12 begins at operation 5710 where a first user input is received by a computing device. For example, as described above, the first user input may be received by application 5622 of computing device 5620. In one particular example, the first user input may indicate that the user is ready to begin the injection process. For example, this may include selection of forward button 5012 of page 5010 of FIG. 5.

[0054] At operation 5712, a first wireless communication is transmitted by the computing device to a wireless receiver integrated with a medication delivery device, such as a medication injection device. The first wireless communication may be transmitted based on a first user input to the computing device. For example, as described above, based on receipt of the first user input, the application 5622 may cause the wireless transmitter 5621 to transmit the first wireless communication to the wireless receiver 5603 integrated with the medication delivery device 5610. The first wireless communication may include control instructions for activating a first light source. Receipt of the first user input by the computing device 5620 (e.g., by the application 5622) may also cause the computing device 5620 (e.g., the application 5622) to load a new display page, such as by switching the display 5624 from page 5010 of FIG. 5 to page 5110 of FIG. 6.

[0055] At operation 5714, a first wireless communication is received from the computing device by the wireless receiver. As described above, the first wireless communication is received via a wireless communication protocol such as a short-range wireless communication protocol (e.g., Bluetooth, Near Field Communication (NFC), etc.).

[0056] In operation 5716, the first light source is activated based on the first wireless communication. The first light source may be, for example, an OLED, an OLED display, an LED, or another type of light source. The first light source may be activated by changing to one or more activation states, such as to start emitting light (e.g., by being powered on), to start blinking, to change color (e.g., to green or another designated color associated with an activation state), etc. As described above, in the example of FIG. 6, the first wireless communication may be received by the wireless receiver 5603 and then by the processing component 5630. In response to receiving the first wireless communication, the processing component 5630 may activate the light source 5611. In the example of FIG. 6, the light source 5611 may be activated by being caused to emit light, such as by being powered on. Specifically, the light source 5611 may be initially unpowered, and the light source 5611 may remain unpowered until the first wireless communication is received by the processing component 5630. When a first wireless communication is received by the processing component 5630, the light source 5611 may be powered on. The switch 5601 is an electrical switch that may control the flow of power from the battery 5604 to the light source 5611. The switch 5601 may initially be in an open state (not allowing power to be provided to the light source 5611) and then moved to a closed state (allowing power to be provided to the light source 5611) when the first wireless communication is received by the processing component 5630. In some examples, the processing component 5630 may provide a signal to close the switch 5601 and allow power to flow to the light source 5611 when the first wireless communication is received.

[0057] Activation of the first light source may be a first visual cue to perform a first step of the instructions for using the drug delivery device. The first step may be, for example, removing the cap, placing the drug delivery device on the user's skin, pressing down, pressing and holding until a click is heard, or lifting the drug delivery device. In one particular example, the first light source may be the light source 5021 of FIG. 6. Also, in one particular example, the first step may be removing the cap of the drug delivery device 5610. As described above, activation of the light source 5021 of FIG. 6 may be a visual cue to remove the cap 320 from the device 300.

[0058] Thus, the first light source may be activated in response (e.g., synchronously) to the first step being displayed by the computing device. The term synchronicity, as used herein, means that the activation of the light source and the start of the display of the step by the computing device occur simultaneously or nearly simultaneously (e.g., with minimal delay due to wireless transmission time, etc.). For example, as shown in FIG. 6, the light source 5021 (which is a cue to remove the cap) may illuminate in response (e.g., synchronously) to the loading of the page 5110 including the instructions 5101 (instructing the user to remove the cap). As described above, the receipt of the first user input may trigger the application 5622 to cause the wireless transmitter 5621 to transmit a first wireless communication to the wireless receiver 5603 integrated with the medication delivery device 5610. The first wireless communication may include a control instruction to activate the first light source (e.g., light source 5021). Receipt of a first user input by computing device 5620 (e.g., by application 5622) may also cause computing device 5620 (e.g., application 5622) to load a new display page, such as by switching display 5624 from page 5010 of Figure 5 to page 5110 of Figure 6. Additionally, light source 5021 may also be deactivated when a user presses forward button 5012 on page 5110 of Figure 6, thereby also switching display 5624 from page 5110 of Figure 6 to page 5210 of Figure 7.

[0059] At operation 5718, a second user input is received by the computing device. For example, as described above, the second user input may be received by the application 5622 of the computing device 5620. For example, upon performing the first step (e.g., removing the cap), a user may provide a second user input to the application 5622 of the computing device 5620. The second user input may indicate to the computing device 5620 that the first step has been performed. For example, the second user input may include a selection of the forward button 5012 of page 5110 of FIG. 6.

[0060] In operation 5720, a second wireless communication is transmitted by the computing device to a wireless receiver integrated with the medication delivery device. The second wireless communication may be transmitted based on a second user input to the computing device indicating that the first step has been performed. For example, as described above, based on receiving the second user input, the application 5622 may cause the wireless transmitter 5621 to transmit a second wireless communication to the wireless receiver 5603 integrated with the medication delivery device 5610. The second wireless communication may include control instructions to activate the second light source (and optionally deactivate the first light source). Receipt of the second user input by the computing device 5620 (e.g., by the application 5622) may also cause the computing device 5620 (e.g., the application 5622) to load a new display page, such as by switching the display 5624 from page 5110 of FIG. 6 to page 5210 of FIG. 7.

[0061] At operation 5722, a second wireless communication is received from the computing device by the wireless receiver. As described above, the second wireless communication is received via a wireless communication protocol.

[0062] At operation 5724, the first light source is deactivated based on the second wireless communication. The first light source may be deactivated by being removed from the state it was in when activated. Thus, for example, the first light source may be deactivated by ceasing to emit light (e.g., by being powered off), ceasing to blink, changing color (e.g., changing back to the color the first light source had before it was activated), etc. As described above with respect to FIG. 6, the second wireless communication may be received by the wireless receiver 5603 and, in turn, by the processing component 5630. In response to receiving the second wireless communication, the processing component 5630 may provide a signal to open the switch 5601, thereby powering off the light source 5611 and causing the light source 5611 to cease emitting light.

[0063] In operation 5726, the second light source is activated based on the second wireless communication. The second light source may be, for example, an OLED, an OLED display, an LED, or another type of light source. The first light source may be activated by changing to one or more activation states, such as to start emitting light (e.g., by being powered on), to start blinking, to change color (e.g., to green or another designated color associated with an activation state), etc. As described above, in the example of FIG. 6, in response to receiving the second wireless communication, the processing component 5630 may also activate the light source 5612. In the example of FIG. 6, the light source 5612 may be activated by being caused to emit light, such as by being powered on. Specifically, the light source 5612 may be initially unpowered, and the light source 5612 may remain unpowered until the second wireless communication is received by the processing component 5630. Once the second wireless communication is received by the processing component 5630, the light source 5612 may be powered on. The switch 5602 is an electrical switch that may control the flow of power from the battery 5604 to the light source 5612. The switch 5602 may initially be in an open state (not allowing power to be provided to the light source 5612) and then moved to a closed state (allowing power to be provided to the light source 5612) upon a second wireless communication being received by the processing component 5630. In some examples, the processing component 5630 may provide a signal to close the switch 5602 and allow power to flow to the light source 5612 upon receiving the second wireless communication.

[0064] Activation of the second light source may be a second visual cue to perform a second step of the instructions for using the drug delivery device. The second step may be, for example, removing the cap, placing the drug delivery device on the user's skin, pressing down, pressing and holding until a click is heard, or lifting the drug delivery device. In one particular example, the second light source may be the light source 5024 of FIG. 7. Also, in one particular example, the second step may be placing the drug delivery device on the user's skin. As described above, activation of the light source 5024 of FIG. 7 may be a visual cue to place the drug delivery device on the user's skin.

[0065] Thus, the second light source may be activated in response to (e.g., synchronously with) the second step being displayed by the computing device. For example, as shown in FIG. 7, the light source 5024 (which is a cue to place the drug delivery device on the user's skin) may illuminate in response to (e.g., synchronously with) loading of the page 5210 including the instructions 5201 (which instruct the user to cue to place the drug delivery device on the user's skin). As described above, receiving the second user input may trigger the application 5622 to cause the wireless transmitter 5621 to transmit a second wireless communication to the wireless receiver 5603 integrated with the drug delivery device 5610. The second wireless communication may include a control instruction to activate the second light source (e.g., the light source 5024). Receipt of a second user input by the computing device 5620 (e.g., by application 5622) may also cause the computing device 5620 (e.g., application 5622) to load a new display page, such as by switching the display 5624 from page 5110 of Figure 6 to page 5210 of Figure 7. Additionally, the light source 5024 may also be deactivated when the user presses the forward button 5012 on page 5110 of Figure 6, which may also cause the display 5624 to switch from page 5210 of Figure 7 to page 5310 of Figure 8.

[0066] As described above, the first step and the second step may be included in the multiple steps of the instructions for using the drug delivery device. In some examples, the multiple steps may be performed in a specified order. For example, the user may remove the cap, then place the drug delivery device on the user's skin, then press down the handle of the drug delivery device, then hold down until a click is heard, and then lift the drug delivery device. In some examples, the second step may be performed immediately after the first step in a specified order. In one particular example, the first step may be removing the cap and the second step may be placing the drug delivery device on the user's skin. In another particular example, the first step may be placing the drug delivery device on the user's skin and the second step may be pressing down the handle of the drug delivery device. In yet another particular example, the first step may be holding down until a click is heard, and the second step may be lifting the drug delivery device. In some examples, the activation of the second light source may indicate that the injection is complete. For example, activation of light source 5023 in Fig. 10 may indicate that the injection is complete. Additionally, in some examples, the computing device may display an indication that the injection is complete. For example, legend 5501 in Fig. 10 indicates that the injection is complete.

[0067] At act 5728, the previous acts 5718-5726 may be repeated for each additional light source (and each respective step of the instructions for use of the medication delivery device). For example, the additional light sources may be activated based on additional communications received by the wireless receiver from the computing device. Further, these additional communications may be transmitted based on user input to the computing device, such as user input indicating that the user has performed a previous step in a specified sequence of steps.

[0068] Although exemplary embodiments of devices for performing the disclosed techniques are described herein, the underlying concepts may be applied to any system capable of performing the techniques as described herein. Thus, the methods and apparatuses described herein may be implemented, or certain aspects or portions thereof, may take the form of program code (e.g., instructions) embodied in a tangible, non-transitory storage medium (e.g., one or more memory components as described above), including a processor-readable or machine-readable storage medium, such that when the program code is loaded into and executed by a machine, the machine becomes an apparatus for performing the techniques described herein.

[0069] While the technology described herein may be implemented in connection with and described in various embodiments in the various drawings, it should be understood that other similar embodiments may be used, or modifications and additions may be made to the described embodiments without departing from them. For example, it should be understood that the steps disclosed above may be performed in the order shown above, or in any other order as desired. The technology described herein should not be limited to any single embodiment, but rather should be construed in breadth and scope in accordance with the appended claims.

Claims

1. 1. A light-based drug delivery cueing system, comprising: a wireless receiver configured to receive a plurality of wireless communications from a computing device via a wireless communication protocol; a first light source activated based on a first wireless communication of the plurality of wireless communications, wherein activation of the first light source is a first visual cue for performing a first step of a plurality of steps of instructions for use of the medication delivery device, the first light source being activated in response to the first step being displayed by the computing device; and a second light source activated based on a second wireless communication of the plurality of wireless communications, wherein activation of the second light source is a second visual cue for performing a second step of the plurality of steps associated with the instructions for use, the second light source being activated in response to the second step being displayed by the computing device, and the second wireless communication being transmitted based on a user input to the computing device; A light-based drug delivery cue system comprising:

2. 10. The light-based medication delivery signaling system of claim 1, wherein the wireless receiver, the first light source, and the second light source are included in one or more adhesive labels attached to the medication delivery device.

3. The light-based medication delivery cue system of claim 1 , wherein the wireless receiver, the first light source, and the second light source are contained within the medication delivery device.

4. The light-based drug delivery cue system of claim 1 , wherein the drug delivery device is a drug injection device.

5. 10. The light-based drug delivery cue system of claim 1, wherein the first light source is an organic light emitting diode (OLED).

6. The light-based drug delivery cueing system of claim 1 , wherein the steps are performed in a specified order.

7. 7. The light-based drug delivery cueing system of claim 6, wherein the second step immediately follows the first step in the specified order.

8. 10. The light-based medication delivery signaling system of claim 1, wherein the first step includes removing a cap, placing the medication delivery device on the user's skin, pressing down, pressing and holding until a click is heard, or lifting the medication delivery device.

9. 10. The light-based medication delivery signaling system of claim 1, wherein the second step includes removing a cap, placing the medication delivery device on the user's skin, pressing down, pressing and holding until a click is heard, or lifting the medication delivery device.

10. The light-based drug delivery cueing system of claim 1 , wherein the user input indicates that the first step has been performed.

11. 10. The light-based drug delivery cueing system of claim 1, wherein activation of the second light source indicates that an injection is complete.

12. The light-based drug delivery cue system of claim 1 , wherein the computing device displays an indication that the injection is complete.

13. 10. The light-based drug delivery cue system of claim 1, wherein the first light source is activated by at least one of causing the first light source to emit light, causing the first light source to flash, or causing the first light source to change color.

14. 10. The light-based drug delivery cue system of claim 1, wherein the second light source is activated by at least one of causing the second light source to emit light, causing the second light source to flash, or causing the second light source to change color.

15. 1. A light-based drug delivery cueing method, comprising: receiving, by a wireless receiver, a first wireless communication from a computing device via a wireless communication protocol; activating a first light source based on the first wireless communication, wherein the activation of the first light source is a first visual cue for performing a first step of a plurality of steps of instructions for use of the medication delivery device, and the first light source is activated in response to the first step being displayed by the computing device; receiving, by the wireless receiver, a second wireless communication from the computing device via the wireless communication protocol, the second wireless communication being transmitted based on user input to the computing device; activating a second light source based on the second wireless communication, wherein activating the second light source is a second visual cue for performing a second step of the plurality of steps associated with the instructions for use, the second light source being activated in response to the second step being displayed by the computing device; A light-based drug delivery cueing method comprising:

16. 16. The light-based drug delivery cue method of claim 15, wherein the wireless receiver, the first light source, and the second light source are included in one or more adhesive labels attached to the drug delivery device.

17. 16. The light-based drug delivery cue method of claim 15, wherein the first step includes removing a cap, placing the drug delivery device on the user's skin, pressing down, pressing and holding until a click is heard, or lifting the drug delivery device.

18. 16. The light-based drug delivery cueing method of claim 15, wherein the user input indicates that the first step has been performed.

Images